詳細(xì)信息
- ;凡德他尼中間體1;1-Boc-4-對(duì)甲苯磺酰氧基哌啶;N-Boc-4-(4-甲苯磺酰氧基甲基)哌啶;
- N-tert-Butoxycarbonyl-4-(4-toluenesulfonyloxymethyl)piperidine
- ;1-Piperidinecarboxylic Acid, 4-[[[(4-Methylphenyl)Sulfonyl]Oxy]Methyl]-, 1,1-Dimethylethyl Ester;N-tert-Butoxycarbonyl-4-(4-toluenesulfonyloxymethyl);tert-butyl 4-({[(4-methylphenyl)sulfonyl]oxy}methyl)piperidine-1-carboxylate;N-Boc-4-(4-toluenesulfonyloxymethyl)piperidine;Vandetanib Intermediate-1;1-N-Boc-4-(4-Toluenesulfonyloxymethyl)piperidine;1-(Tert-Butoxycarbonyl)-4-[[(P-Tolylsulfonyl)Oxy]Methyl]Piperidine;tert-butyl 4-((tosyloxy)methyl)piperidine-1-carboxylate;
- InChI=1/C18H27NO5S/c1-14-5-7-16(8-6-14)25(21,22)23-13-15-9-11-19(12-10-15)17(20)24-18(2,3)4/h5-8,15H,9-13H2,1-4H3
- 1.175g/cm3
- 487.784°C at 760 mmHg
- 248.803°C
免責(zé)聲明:以上所展示的信息由企業(yè)自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布企業(yè)負(fù)責(zé),化工網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。我們?cè)瓌t上建議您選擇化工網(wǎng)高級(jí)會(huì)員或VIP會(huì)員。

